APO Research
Talk to an analyst

APO RESEARCH · REPORT

NSAIDs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global NSAIDs Market Outlook and Growth Opportunities 2026

26 December 2025192 pages

Choose your research edition.

Industry ResearchNSAIDs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal NSAIDs Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal NSAIDs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NSAIDs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal NSAIDs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global NSAIDs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the NSAIDs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the NSAIDs market include Cigna, Geri-Care Pharmaceuticals, GlaxoSmithKline, Kopran, Novacap, Perrigo Company, Reddy Pharmaceuticals, Sun Pharmaceutical Industries and Verywell, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global NSAIDs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NSAIDs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NSAIDs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the NSAIDs market size, projected growth trends, production technologies, key applications, and end-use industries.

NSAIDs Segment by Company

Cigna

Geri-Care Pharmaceuticals

GlaxoSmithKline

Kopran

Novacap

Perrigo Company

Reddy Pharmaceuticals

Sun Pharmaceutical Industries

Verywell

Bayer

Pfizer

Merck Sharp & Dohme

Johnson & Johnson

Abbott

NSAIDs Segment by Type

Naproxen

Nabumetone

Ibuprofen

Aspirin

Others

NSAIDs Segment by Application

Back Pain Treatment

Osteoarthritis Treatment

Other Disease Treatment

NSAIDs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global NSAIDs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions NSAIDs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify NSAIDs significant trends, drivers, influence factors in global and regions.

6. To analyze NSAIDs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NSAIDs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NSAIDs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NSAIDs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the NSAIDs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global NSAIDs industry.

Chapter 3: Detailed analysis of NSAIDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of NSAIDs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of NSAIDs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. NSAIDs Industry Trends Table 2. NSAIDs Industry Drivers Table 3. NSAIDs Industry Opportunities and Challenges Table 4. NSAIDs Industry Restraints Table 5. Global NSAIDs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global NSAIDs Revenue Share by Company (2021-2026) Table 7. Global NSAIDs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global NSAIDs Sales Volume Share by Company (2021-2026) Table 9. Global NSAIDs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global NSAIDs Company Ranking, (2024-2026) & (USD Million) Table 11. Global NSAIDs Key Company Manufacturing Base & Headquarters Table 12. Global NSAIDs Company, Product Type & Application Table 13. Global NSAIDs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global NSAIDs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Naproxen Table 18. Significant Companies of Nabumetone Table 19. Significant Companies of Ibuprofen Table 20. Significant Companies of Aspirin Table 21. Significant Companies of Others Table 22. Global NSAIDs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global NSAIDs Sales Volume by Type (2021-2026) & (K Units) Table 24. Global NSAIDs Sales Volume by Type (2027-2032) & (K Units) Table 25. Global NSAIDs Sales Volume Share by Type (2021-2026) Table 26. Global NSAIDs Sales Volume Share by Type (2027-2032) Table 27. Global NSAIDs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global NSAIDs Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global NSAIDs Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global NSAIDs Sales Value Share by Type (2021-2026) Table 31. Global NSAIDs Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Back Pain Treatment Table 33. Significant Companies of Osteoarthritis Treatment Table 34. Significant Companies of Other Disease Treatment Table 35. Global NSAIDs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global NSAIDs Sales Volume by Application (2021-2026) & (K Units) Table 37. Global NSAIDs Sales Volume by Application (2027-2032) & (K Units) Table 38. Global NSAIDs Sales Volume Share by Application (2021-2026) Table 39. Global NSAIDs Sales Volume Share by Application (2027-2032) Table 40. Global NSAIDs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global NSAIDs Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global NSAIDs Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global NSAIDs Sales Value Share by Application (2021-2026) Table 44. Global NSAIDs Sales Value Share by Application (2027-2032) Table 45. Global NSAIDs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global NSAIDs Sales by Region (2021-2026) & (K Units) Table 47. Global NSAIDs Sales Market Share by Region (2021-2026) Table 48. Global NSAIDs Sales by Region (2027-2032) & (K Units) Table 49. Global NSAIDs Sales Market Share by Region (2027-2032) Table 50. Global NSAIDs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global NSAIDs Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global NSAIDs Sales Value Share by Region (2021-2026) Table 53. Global NSAIDs Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global NSAIDs Sales Value Share by Region (2027-2032) Table 55. Global NSAIDs Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global NSAIDs Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global NSAIDs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global NSAIDs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global NSAIDs Sales by Country (2021-2026) & (K Units) Table 60. Global NSAIDs Sales Market Share by Country (2021-2026) Table 61. Global NSAIDs Sales by Country (2027-2032) & (K Units) Table 62. Global NSAIDs Sales Market Share by Country (2027-2032) Table 63. Global NSAIDs Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global NSAIDs Sales Value Market Share by Country (2021-2026) Table 65. Global NSAIDs Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global NSAIDs Sales Value Market Share by Country (2027-2032) Table 67. Cigna Company Information Table 68. Cigna Business Overview Table 69. Cigna NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Cigna NSAIDs Product Portfolio Table 71. Cigna Recent Development Table 72. Geri-Care Pharmaceuticals Company Information Table 73. Geri-Care Pharmaceuticals Business Overview Table 74. Geri-Care Pharmaceuticals NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Geri-Care Pharmaceuticals NSAIDs Product Portfolio Table 76. Geri-Care Pharmaceuticals Recent Development Table 77. GlaxoSmithKline Company Information Table 78. GlaxoSmithKline Business Overview Table 79. GlaxoSmithKline NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. GlaxoSmithKline NSAIDs Product Portfolio Table 81. GlaxoSmithKline Recent Development Table 82. Kopran Company Information Table 83. Kopran Business Overview Table 84. Kopran NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Kopran NSAIDs Product Portfolio Table 86. Kopran Recent Development Table 87. Novacap Company Information Table 88. Novacap Business Overview Table 89. Novacap NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Novacap NSAIDs Product Portfolio Table 91. Novacap Recent Development Table 92. Perrigo Company Company Information Table 93. Perrigo Company Business Overview Table 94. Perrigo Company NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Perrigo Company NSAIDs Product Portfolio Table 96. Perrigo Company Recent Development Table 97. Reddy Pharmaceuticals Company Information Table 98. Reddy Pharmaceuticals Business Overview Table 99. Reddy Pharmaceuticals NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Reddy Pharmaceuticals NSAIDs Product Portfolio Table 101. Reddy Pharmaceuticals Recent Development Table 102. Sun Pharmaceutical Industries Company Information Table 103. Sun Pharmaceutical Industries Business Overview Table 104. Sun Pharmaceutical Industries NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Sun Pharmaceutical Industries NSAIDs Product Portfolio Table 106. Sun Pharmaceutical Industries Recent Development Table 107. Verywell Company Information Table 108. Verywell Business Overview Table 109. Verywell NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Verywell NSAIDs Product Portfolio Table 111. Verywell Recent Development Table 112. Bayer Company Information Table 113. Bayer Business Overview Table 114. Bayer NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Bayer NSAIDs Product Portfolio Table 116. Bayer Recent Development Table 117. Pfizer Company Information Table 118. Pfizer Business Overview Table 119. Pfizer NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Pfizer NSAIDs Product Portfolio Table 121. Pfizer Recent Development Table 122. Merck Sharp & Dohme Company Information Table 123. Merck Sharp & Dohme Business Overview Table 124. Merck Sharp & Dohme NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Merck Sharp & Dohme NSAIDs Product Portfolio Table 126. Merck Sharp & Dohme Recent Development Table 127. Johnson & Johnson Company Information Table 128. Johnson & Johnson Business Overview Table 129. Johnson & Johnson NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Johnson & Johnson NSAIDs Product Portfolio Table 131. Johnson & Johnson Recent Development Table 132. Abbott Company Information Table 133. Abbott Business Overview Table 134. Abbott NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Abbott NSAIDs Product Portfolio Table 136. Abbott Recent Development Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. NSAIDs Distributors List Table 140. NSAIDs Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. NSAIDs Product Image Figure 2. Global NSAIDs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NSAIDs Sales Value (2021-2032) & (US$ Million) Figure 4. Global NSAIDs Sales (2021-2032) & (K Units) Figure 5. Global NSAIDs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global NSAIDs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Naproxen Image Figure 10. Nabumetone Image Figure 11. Ibuprofen Image Figure 12. Aspirin Image Figure 13. Others Image Figure 14. Global NSAIDs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global NSAIDs Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global NSAIDs Sales Volume Share by Type (2021-2032) Figure 17. Global NSAIDs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global NSAIDs Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global NSAIDs Sales Value Share by Type (2021-2032) Figure 20. Back Pain Treatment Image Figure 21. Osteoarthritis Treatment Image Figure 22. Other Disease Treatment Image Figure 23. Global NSAIDs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global NSAIDs Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global NSAIDs Sales Volume Share by Application (2021-2032) Figure 26. Global NSAIDs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global NSAIDs Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global NSAIDs Sales Value Share by Application (2021-2032) Figure 29. Global NSAIDs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global NSAIDs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global NSAIDs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global NSAIDs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America NSAIDs Sales Value (2021-2032) & (US$ Million) Figure 34. North America NSAIDs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe NSAIDs Sales Value (2021-2032) & (US$ Million) Figure 36. Europe NSAIDs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific NSAIDs Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific NSAIDs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America NSAIDs Sales Value (2021-2032) & (US$ Million) Figure 40. South America NSAIDs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa NSAIDs Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa NSAIDs Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt NSAIDs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt NSAIDs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt NSAIDs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. NSAIDs Value Chain Figure 128. Manufacturing Cost Structure Figure 129. NSAIDs Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Naproxen
  • Nabumetone
  • Ibuprofen
  • Aspirin
  • Others
Applications
  • Back Pain Treatment
  • Osteoarthritis Treatment
  • Other Disease Treatment
Companies covered
  • Cigna
  • Geri-Care Pharmaceuticals
  • GlaxoSmithKline
  • Kopran
  • Novacap
  • Perrigo Company
  • Reddy Pharmaceuticals
  • Sun Pharmaceutical Industries
  • Verywell
  • Bayer
  • Pfizer
  • Merck Sharp & Dohme
  • Johnson & Johnson
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global NSAIDs Sales Value (2021-2032)
  4. 1.2.2 Global NSAIDs Sales Volume (2021-2032)
  5. 1.2.3 Global NSAIDs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 NSAIDs Market Dynamics
  1. 2.1 NSAIDs Industry Trends
  2. 2.2 NSAIDs Industry Drivers
  3. 2.3 NSAIDs Industry Opportunities and Challenges
  4. 2.4 NSAIDs Industry Restraints
3 NSAIDs Market by Company
  1. 3.1 Global NSAIDs Company Revenue Ranking in 2025
  2. 3.2 Global NSAIDs Revenue by Company (2021-2026)
  3. 3.3 Global NSAIDs Sales Volume by Company (2021-2026)
  4. 3.4 Global NSAIDs Average Price by Company (2021-2026)
  5. 3.5 Global NSAIDs Company Ranking (2024-2026)
  6. 3.6 Global NSAIDs Company Manufacturing Base and Headquarters
  7. 3.7 Global NSAIDs Company Product Type and Application
  8. 3.8 Global NSAIDs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global NSAIDs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 NSAIDs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 NSAIDs Market by Type
  1. 4.1 NSAIDs Type Introduction
  2. 4.1.1 Naproxen
  3. 4.1.2 Nabumetone
  4. 4.1.3 Ibuprofen
  5. 4.1.4 Aspirin
  6. 4.1.5 Others
  7. 4.2 Global NSAIDs Sales Volume by Type
  8. 4.2.1 Global NSAIDs Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global NSAIDs Sales Volume by Type (2021-2032)
  10. 4.2.3 Global NSAIDs Sales Volume Share by Type (2021-2032)
  11. 4.3 Global NSAIDs Sales Value by Type
  12. 4.3.1 Global NSAIDs Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global NSAIDs Sales Value by Type (2021-2032)
  14. 4.3.3 Global NSAIDs Sales Value Share by Type (2021-2032)
5 NSAIDs Market by Application
  1. 5.1 NSAIDs Application Introduction
  2. 5.1.1 Back Pain Treatment
  3. 5.1.2 Osteoarthritis Treatment
  4. 5.1.3 Other Disease Treatment
  5. 5.2 Global NSAIDs Sales Volume by Application
  6. 5.2.1 Global NSAIDs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global NSAIDs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global NSAIDs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global NSAIDs Sales Value by Application
  10. 5.3.1 Global NSAIDs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global NSAIDs Sales Value by Application (2021-2032)
  12. 5.3.3 Global NSAIDs Sales Value Share by Application (2021-2032)
6 NSAIDs Regional Sales and Value Analysis
  1. 6.1 Global NSAIDs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global NSAIDs Sales by Region (2021-2032)
  3. 6.2.1 Global NSAIDs Sales by Region: 2021-2026
  4. 6.2.2 Global NSAIDs Sales by Region (2027-2032)
  5. 6.3 Global NSAIDs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global NSAIDs Sales Value by Region (2021-2032)
  7. 6.4.1 Global NSAIDs Sales Value by Region: 2021-2026
  8. 6.4.2 Global NSAIDs Sales Value by Region (2027-2032)
  9. 6.5 Global NSAIDs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America NSAIDs Sales Value (2021-2032)
  12. 6.6.2 North America NSAIDs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe NSAIDs Sales Value (2021-2032)
  15. 6.7.2 Europe NSAIDs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific NSAIDs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific NSAIDs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America NSAIDs Sales Value (2021-2032)
  21. 6.9.2 South America NSAIDs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa NSAIDs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa NSAIDs Sales Value Share by Country, 2025 VS 2032
7 NSAIDs Country-level Sales and Value Analysis
  1. 7.1 Global NSAIDs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global NSAIDs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global NSAIDs Sales by Country (2021-2032)
  4. 7.3.1 Global NSAIDs Sales by Country (2021-2026)
  5. 7.3.2 Global NSAIDs Sales by Country (2027-2032)
  6. 7.4 Global NSAIDs Sales Value by Country (2021-2032)
  7. 7.4.1 Global NSAIDs Sales Value by Country (2021-2026)
  8. 7.4.2 Global NSAIDs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA NSAIDs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA NSAIDs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA NSAIDs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada NSAIDs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada NSAIDs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada NSAIDs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico NSAIDs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico NSAIDs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico NSAIDs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany NSAIDs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany NSAIDs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany NSAIDs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France NSAIDs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France NSAIDs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France NSAIDs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. NSAIDs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. NSAIDs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. NSAIDs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy NSAIDs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy NSAIDs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy NSAIDs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain NSAIDs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain NSAIDs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain NSAIDs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia NSAIDs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia NSAIDs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia NSAIDs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands NSAIDs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands NSAIDs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands NSAIDs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries NSAIDs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries NSAIDs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries NSAIDs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China NSAIDs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China NSAIDs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China NSAIDs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan NSAIDs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan NSAIDs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan NSAIDs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea NSAIDs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea NSAIDs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea NSAIDs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India NSAIDs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India NSAIDs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India NSAIDs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia NSAIDs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia NSAIDs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia NSAIDs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia NSAIDs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia NSAIDs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia NSAIDs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil NSAIDs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil NSAIDs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil NSAIDs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina NSAIDs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina NSAIDs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina NSAIDs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile NSAIDs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile NSAIDs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile NSAIDs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia NSAIDs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia NSAIDs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia NSAIDs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru NSAIDs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru NSAIDs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru NSAIDs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia NSAIDs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia NSAIDs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia NSAIDs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel NSAIDs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel NSAIDs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel NSAIDs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE NSAIDs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE NSAIDs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE NSAIDs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey NSAIDs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey NSAIDs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey NSAIDs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran NSAIDs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran NSAIDs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran NSAIDs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt NSAIDs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt NSAIDs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt NSAIDs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cigna
  2. 8.1.1 Cigna Company Information
  3. 8.1.2 Cigna Business Overview
  4. 8.1.3 Cigna NSAIDs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Cigna NSAIDs Product Portfolio
  6. 8.1.5 Cigna Recent Developments
  7. 8.2 Geri-Care Pharmaceuticals
  8. 8.2.1 Geri-Care Pharmaceuticals Company Information
  9. 8.2.2 Geri-Care Pharmaceuticals Business Overview
  10. 8.2.3 Geri-Care Pharmaceuticals NSAIDs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Geri-Care Pharmaceuticals NSAIDs Product Portfolio
  12. 8.2.5 Geri-Care Pharmaceuticals Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline NSAIDs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline NSAIDs Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 Kopran
  20. 8.4.1 Kopran Company Information
  21. 8.4.2 Kopran Business Overview
  22. 8.4.3 Kopran NSAIDs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Kopran NSAIDs Product Portfolio
  24. 8.4.5 Kopran Recent Developments
  25. 8.5 Novacap
  26. 8.5.1 Novacap Company Information
  27. 8.5.2 Novacap Business Overview
  28. 8.5.3 Novacap NSAIDs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Novacap NSAIDs Product Portfolio
  30. 8.5.5 Novacap Recent Developments
  31. 8.6 Perrigo Company
  32. 8.6.1 Perrigo Company Company Information
  33. 8.6.2 Perrigo Company Business Overview
  34. 8.6.3 Perrigo Company NSAIDs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Perrigo Company NSAIDs Product Portfolio
  36. 8.6.5 Perrigo Company Recent Developments
  37. 8.7 Reddy Pharmaceuticals
  38. 8.7.1 Reddy Pharmaceuticals Company Information
  39. 8.7.2 Reddy Pharmaceuticals Business Overview
  40. 8.7.3 Reddy Pharmaceuticals NSAIDs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Reddy Pharmaceuticals NSAIDs Product Portfolio
  42. 8.7.5 Reddy Pharmaceuticals Recent Developments
  43. 8.8 Sun Pharmaceutical Industries
  44. 8.8.1 Sun Pharmaceutical Industries Company Information
  45. 8.8.2 Sun Pharmaceutical Industries Business Overview
  46. 8.8.3 Sun Pharmaceutical Industries NSAIDs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharmaceutical Industries NSAIDs Product Portfolio
  48. 8.8.5 Sun Pharmaceutical Industries Recent Developments
  49. 8.9 Verywell
  50. 8.9.1 Verywell Company Information
  51. 8.9.2 Verywell Business Overview
  52. 8.9.3 Verywell NSAIDs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Verywell NSAIDs Product Portfolio
  54. 8.9.5 Verywell Recent Developments
  55. 8.10 Bayer
  56. 8.10.1 Bayer Company Information
  57. 8.10.2 Bayer Business Overview
  58. 8.10.3 Bayer NSAIDs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Bayer NSAIDs Product Portfolio
  60. 8.10.5 Bayer Recent Developments
  61. 8.11 Pfizer
  62. 8.11.1 Pfizer Company Information
  63. 8.11.2 Pfizer Business Overview
  64. 8.11.3 Pfizer NSAIDs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Pfizer NSAIDs Product Portfolio
  66. 8.11.5 Pfizer Recent Developments
  67. 8.12 Merck Sharp & Dohme
  68. 8.12.1 Merck Sharp & Dohme Company Information
  69. 8.12.2 Merck Sharp & Dohme Business Overview
  70. 8.12.3 Merck Sharp & Dohme NSAIDs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Merck Sharp & Dohme NSAIDs Product Portfolio
  72. 8.12.5 Merck Sharp & Dohme Recent Developments
  73. 8.13 Johnson & Johnson
  74. 8.13.1 Johnson & Johnson Company Information
  75. 8.13.2 Johnson & Johnson Business Overview
  76. 8.13.3 Johnson & Johnson NSAIDs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Johnson & Johnson NSAIDs Product Portfolio
  78. 8.13.5 Johnson & Johnson Recent Developments
  79. 8.14 Abbott
  80. 8.14.1 Abbott Company Information
  81. 8.14.2 Abbott Business Overview
  82. 8.14.3 Abbott NSAIDs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Abbott NSAIDs Product Portfolio
  84. 8.14.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 NSAIDs Value Chain Analysis
  2. 9.1.1 NSAIDs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 NSAIDs Sales Mode & Process
  6. 9.2 NSAIDs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 NSAIDs Distributors
  9. 9.2.3 NSAIDs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst